Phase III Randomized Study of RFS 2000 (9-Nitro-Camptothecin, 9-NC) Versus 5-Fluorouracil (5-FU) in Pancreatic Cancer Patients That Have Progressive Disease Following Gemcitabine HCl Treatment.
Latest Information Update: 29 Jan 2020
At a glance
- Drugs Rubitecan (Primary) ; Fluorouracil
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors Astex Pharmaceuticals
- 04 Sep 2005 New trial record.